Dendritic Studies

CIKA is committed to providing funding for research into solid tumors


Dendritic Studies - Cancer in Kids @ RCH - CIKA

The Dendritic Studies programme was carried out in the Tumour Laboratory at the RCH. Its purpose was to leverage results found in earlier vaccine studies and determine why cancer patients become immunodeficient.

Expected Outcomes:
Reduction of immunodeficiency will enable treatment protocols to be completed on schedule. Patients comfort will be increased due to better health, costs will be reduced through less hospital admissions.

CIKA Funding Commencement:
2003 (earlier funding of vaccine studies commenced in 1997)

Expected Completion:
2006

Milestones:
NHMRC Funding in 2007.
Development of mouse models.

Cancers targetted:
Neuroblastoma, recurrent solid and brain tumours.

Achievements to date:
Identified co-stimulation molecules. Research accepted and published in scientific journals.


The CIKA Newsletter for summer 2005 contained an interim report on the progress of this project. It can be read by clicking here.